MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
AVITA Medical Retained Earnings 2011-2026 | RCEL
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -408 M | -360 M | -298 M | -263 M | -236 M | -195 M | -129 M | -109 M | -102 M | -90.4 M | -87 M | -100 M | -94.9 M | -98.9 M | -95.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -87 M | -408 M | -178 M |
Quarterly Retained Earnings AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -397 M | -374 M | -360 M | -348 M | -332 M | -317 M | -298 M | -291 M | -282 M | -272 M | -263 M | -257 M | -252 M | -245 M | -236 M | -227 M | -221 M | -221 M | -211 M | -205 M | -195 M | -195 M | - | - | -153 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -153 M | -397 M | -267 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M |  USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.88 | -1.02 % | $ 134 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 6.9 | -4.17 % | $ 495 M |  Israel |
 |
Alphatec Holdings
ATEC
|
-1.28 B | $ 13.17 | -2.23 % | $ 1.88 B | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 292.08 | -0.55 % | $ 8.24 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 36.61 | -13.72 % | $ 5.46 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
560 M | $ 41.57 | -1.8 % | $ 1.28 B | USA |
 |
Boston Scientific Corporation
BSX
|
2.67 B | $ 74.23 | 1.03 % | $ 109 B | USA |
 |
Abbott Laboratories
ABT
|
47.3 B | $ 112.24 | -1.19 % | $ 195 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 13.0 | -2.8 % | $ 351 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.82 | -1.73 % | $ 180 M |  France |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Electromed
ELMD
|
21.2 M | $ 23.39 | -7.4 % | $ 198 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
875 M | $ 14.36 | 0.81 % | $ 1.14 B | Israel |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.54 | -0.22 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
1.15 B | $ 87.0 | -1.43 % | $ 11.8 B | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 99.45 | -3.52 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
891 M | $ 84.9 | -2.62 % | $ 2.85 B | USA |
 |
Myomo
MYO
|
-88.8 M | $ 0.8 | 0.29 % | $ 5.64 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
940 M | $ 10.88 | -2.68 % | $ 838 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-445 M | $ 72.93 | 0.29 % | $ 2.05 B |  Costa-rica |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.35 | -5.59 % | $ 21.8 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.63 | 1.76 % | $ 34.3 M | USA |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.44 | -1.03 % | $ 56.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-236 M | $ 16.62 | -3.48 % | $ 384 M | USA |